- Home
- CMPX vs ARAY Comparison
CMPX vs ARAY Comparison
Compare CMPX & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- ARAY
- Stock Information
- Founded
- CMPX 2014
- ARAY 1990
- Country
- CMPX United States
- ARAY United States
- Employees
- CMPX N/A
- ARAY N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- ARAY Medical/Dental Instruments
- Sector
- CMPX Health Care
- ARAY Health Care
- Exchange
- CMPX Nasdaq
- ARAY Nasdaq
- Market Cap
- CMPX 214.6M
- ARAY 180.0M
- IPO Year
- CMPX N/A
- ARAY 2007
- Fundamental
- Price
- CMPX $2.60
- ARAY $2.24
- Analyst Decision
- CMPX Strong Buy
- ARAY Strong Buy
- Analyst Count
- CMPX 4
- ARAY 1
- Target Price
- CMPX $13.75
- ARAY $9.00
- AVG Volume (30 Days)
- CMPX 2.2M
- ARAY 669.1K
- Earning Date
- CMPX 11-12-2024
- ARAY 01-29-2025
- Dividend Yield
- CMPX N/A
- ARAY N/A
- EPS Growth
- CMPX N/A
- ARAY N/A
- EPS
- CMPX N/A
- ARAY N/A
- Revenue
- CMPX $850,000.00
- ARAY $444,204,000.00
- Revenue This Year
- CMPX N/A
- ARAY $6.64
- Revenue Next Year
- CMPX $613.39
- ARAY $5.69
- P/E Ratio
- CMPX N/A
- ARAY N/A
- Revenue Growth
- CMPX N/A
- ARAY N/A
- 52 Week Low
- CMPX $0.77
- ARAY $1.40
- 52 Week High
- CMPX $2.70
- ARAY $2.99
- Technical
- Relative Strength Index (RSI)
- CMPX 76.97
- ARAY 60.03
- Support Level
- CMPX $1.43
- ARAY $2.04
- Resistance Level
- CMPX $2.70
- ARAY $2.34
- Average True Range (ATR)
- CMPX 0.29
- ARAY 0.15
- MACD
- CMPX 0.12
- ARAY 0.03
- Stochastic Oscillator
- CMPX 92.31
- ARAY 82.76
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.